Hyperkinetic children: the use of stimulant drugs evaluated.
Use of stimulant drugs in the treatment of hyperkinetic children is reviewed briefly. While drugs appear to be effective in "normalizing" behavior, too little attention has been paid to potential side effects. There is need for a broader program of clinical evaluation, assessing drug effects not only on behavior, but on appetite and the cardiovascular system, and taking into account the sociological impact of drug use by children.
D000124:Achievement; D000818:Animals; D001288:Attention / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D003913:Dextroamphetamine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D008774:Methylphenidate / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012154:Reticular Formation / Q000187:drug effects; D019966:Substance-Related Disorders / Q000209:etiology; D009435:Synaptic Transmission / Q000187:drug effects
D008774:Methylphenidate; D003913:Dextroamphetamine; D009638:Norepinephrine